BTMD biote Corp.
Healthcare$1.92-3.52%ClosedMarket Cap: $84.7M
As of 2026-05-26
Valuation
P/E (TTM)
2.59
PEG
0.00
P/B
-1.09
P/S
0.47
EV/EBITDA
5.34
DCF Value
$3.86
FCF Yield
32.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
68.5%
Operating Margin
17.0%
Net Margin
8.3%
ROE
-22.9%
ROA
17.5%
ROIC
37.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $44.9M | 67.1% | $4.5M | $2.3M | $— | — |
| Q4 null | $46.4M | 66.4% | $7.2M | $2.0M | $— | — |
| FY null | $192.2M | 69.8% | $39.1M | $27.0M | $— | — |
| Q3 null | $48.0M | 70.2% | $8.7M | $8.2M | $— | — |
| Q2 null | $48.9M | 69.9% | $11.6M | $3.2M | $— | — |
| Q1 null | $49.0M | 72.5% | $10.5M | $13.7M | $— | — |
| Q4 null | $49.8M | 71.3% | $2.8M | $3.7M | $— | — |
| FY null | $197.2M | 70.5% | $31.6M | $3.2M | $— | — |
| Q3 null | $51.4M | 70.5% | $12.2M | $10.7M | $— | — |
| Q2 null | $49.2M | 68.9% | $6.2M | $-6.3M | $— | — |
| Q1 null | $46.8M | 71.3% | $10.4M | $-4.2M | $— | — |
| Q4 2023 | $45.7M | 69.4% | $5.5M | $7.7M | $0.12 | — |